Literature DB >> 23594188

Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.

Susumu Ohya1, Erina Nakamura, Sayuri Horiba, Hiroaki Kito, Miki Matsui, Hisao Yamamura, Yuji Imaizumi.   

Abstract

BACKGROUND AND
PURPOSE: The intermediate-conductance Ca(2+)-activated K(+) channel (K(Ca)3.1) modulates the Ca(2+) response through the control of the membrane potential in the immune system. We investigated the role of K(Ca)3.1 on the pathogenesis of delayed-type hypersensitivity (DTH) in auricular lymph node (ALN) CD4(+) T-lymphocytes of oxazolone (Ox)-induced DTH model mice. EXPERIMENTAL APPROACH: The expression patterns of K(Ca)3.1 and its possible transcriptional regulators were compared among ALN T-lymphocytes of three groups [non-sensitized (Ox-/-), Ox-sensitized, but non-challenged (Ox+/-) and Ox-sensitized and -challenged (Ox+/+)] using real-time polymerase chain reaction, Western blotting and flow cytometry. KCa 3.1 activity was measured by whole-cell patch clamp and the voltage-sensitive dye imaging. The effects of K(Ca)3.1 blockade were examined by the administration of selective K(Ca)3.1 blockers. KEY
RESULTS: Significant up-regulation of K(Ca)3.1a was observed in CD4(+) T-lymphocytes of Ox+/- and Ox+/+, without any evident changes in the expression of the dominant-negative form, K(Ca)3.1b. Negatively correlated with this, the repressor element-1 silencing transcription factor (REST) was significantly down-regulated. Pharmacological blockade of K(Ca)3.1 resulted in an accumulation of the CD4(+) T-lymphocytes of Ox+/+ at the G0/G1 phase of the cell cycle, and also significantly recovered not only the pathogenesis of DTH, but also the changes in the K(Ca)3.1 expression and activity in the CD4(+) T-lymphocytes of Ox+/- and Ox+/+. CONCLUSIONS AND IMPLICATIONS: The up-regulation of K(Ca)3.1a in conjunction with the down-regulation of REST may be involved in CD4(+) T-lymphocyte proliferation in the ALNs of DTH model mice; and K(Ca)3.1 may be an important target for therapeutic intervention in allergy diseases such as DTH.
© 2013 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594188      PMCID: PMC3696325          DOI: 10.1111/bph.12215

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.

Authors:  Zoltan Varga; Georgina Gurrola-Briones; Ferenc Papp; Ricardo C Rodríguez de la Vega; Gustavo Pedraza-Alva; Rajeev B Tajhya; Rezso Gaspar; Luis Cardenas; Yvonne Rosenstein; Christine Beeton; Lourival D Possani; Gyorgy Panyi
Journal:  Mol Pharmacol       Date:  2012-05-23       Impact factor: 4.436

2.  Cardioprotective effects of estradiol include the activation of large-conductance Ca(2+)-activated K(+) channels in cardiac mitochondria.

Authors:  Susumu Ohya; Yukiko Kuwata; Kazuho Sakamoto; Katsuhiko Muraki; Yuji Imaizumi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-08-19       Impact factor: 4.733

3.  Novel functions of small conductance Ca2+-activated K+ channel in enhanced cell proliferation by ATP in brain endothelial cells.

Authors:  Daiju Yamazaki; Mineyoshi Aoyama; Susumu Ohya; Katsuhiko Muraki; Kiyofumi Asai; Yuji Imaizumi
Journal:  J Biol Chem       Date:  2006-10-24       Impact factor: 5.157

4.  Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.

Authors:  Thomas Gebhardt; Paul G Whitney; Ali Zaid; Laura K Mackay; Andrew G Brooks; William R Heath; Francis R Carbone; Scott N Mueller
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

5.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

6.  Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.

Authors:  Susumu Ohya; Satomi Niwa; Yoshiyuki Kojima; Shoichi Sasaki; Motomu Sakuragi; Kenjiro Kohri; Yuji Imaizumi
Journal:  J Pharmacol Exp Ther       Date:  2011-05-20       Impact factor: 4.030

7.  Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.

Authors:  Ralf Köhler; Heike Wulff; Ines Eichler; Marlene Kneifel; Daniel Neumann; Andrea Knorr; Ivica Grgic; Doris Kämpfe; Han Si; Judith Wibawa; Robert Real; Klaus Borner; Susanne Brakemeier; Hans-Dieter Orzechowski; Hans-Peter Reusch; Martin Paul; K George Chandy; Joachim Hoyer
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

8.  Drug-induced regulation of target expression.

Authors:  Murat Iskar; Monica Campillos; Michael Kuhn; Lars Juhl Jensen; Vera van Noort; Peer Bork
Journal:  PLoS Comput Biol       Date:  2010-09-09       Impact factor: 4.475

9.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

10.  KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.

Authors:  Aurelie Chantome; Alban Girault; Marie Potier; Christine Collin; Pascal Vaudin; Jean-Christophe Pagès; Christophe Vandier; Virginie Joulin
Journal:  Exp Cell Res       Date:  2009-07-30       Impact factor: 3.905

View more
  3 in total

1.  The expression and functional evidence for voltage-dependent potassium channel Kv1.3 in lymphocytes during aging in spontaneously hypertensive rats.

Authors:  Ling-Peng Wang; Jian Luo; Hai-Feng Hu; Li Zhang; Ya-Li Li; Li-Man Ai; Yu-Ling Wang; Yi-Tong Ma; Hu-Yati Mu; Yue-Mei Hou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions.

Authors:  Eugene Y Chiang; Tianbo Li; Surinder Jeet; Ivan Peng; Juan Zhang; Wyne P Lee; Jason DeVoss; Patrick Caplazi; Jun Chen; Søren Warming; David H Hackos; Susmith Mukund; Christopher M Koth; Jane L Grogan
Journal:  Nat Commun       Date:  2017-03-01       Impact factor: 14.919

3.  Pathophysiological significance of the two-pore domain K(+) channel K2P5.1 in splenic CD4(+)CD25(-) T cell subset from a chemically-induced murine inflammatory bowel disease model.

Authors:  Sawa Nakakura; Miki Matsui; Aya Sato; Mizuki Ishii; Kyoko Endo; Sayaka Muragishi; Miki Murase; Hiroaki Kito; Hiroki Niguma; Natsumi Kurokawa; Masanori Fujii; Masatake Araki; Kimi Araki; Susumu Ohya
Journal:  Front Physiol       Date:  2015-10-27       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.